Quarterly report pursuant to Section 13 or 15(d)

PARENT COMPANY FINANCIALS. (Details 2)

v3.20.1
PARENT COMPANY FINANCIALS. (Details 2) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Activities:    
Net loss $ (25,100) $ (12,890)
Adjustments to reconcile net loss to cash used in operating activities:    
Amortization (accretion) of debt discount (premium) (57) 178
Changes in operating assets and liabilities:    
Receivables from subsidiaries 22,024 (9,970)
Accounts payable and accrued expenses (1,512) 273
Net cash used in operating activities 26,901 (15,027)
Investing Activities:    
Additions to property and equipment (1,245) (1,112)
Net cash used in investing activities (1,245) (1,112)
Financing Activities:    
Proceeds from issuances of common stock 282 3,670
Net cash provided by (used in) financing activities (17,874) 11,263
Net increase (decrease) in cash and cash equivalents 7,782 (4,876)
Cash and cash equivalents at beginning of period 18,997 [1] 26,627
Cash and cash equivalents at end of period 26,779 21,751
Parent Company [Member]    
Operating Activities:    
Net loss (25,100) (12,890)
Adjustments to reconcile net loss to cash used in operating activities:    
Equity in losses of subsidiaries 22,051 10,194
Fair value adjustments (673)
Depreciation 33 75
Amortization (accretion) of debt discount (premium) (57) 178
Changes in operating assets and liabilities:    
Receivables from subsidiaries 123 1,778
Other assets 29 (264)
Accounts payable and accrued expenses 45
Accounts payable with subsidiaries 2,235 797
Net cash used in operating activities (1,359) (87)
Investing Activities:    
Additions to property and equipment
Net cash used in investing activities
Financing Activities:    
Proceeds from issuances of common stock 282 3,670
Proceeds from plant receivable 5,813
Payments on senior notes (3,748)
Preferred stock dividend payments (312)
Net cash provided by (used in) financing activities 6,095 (390)
Net increase (decrease) in cash and cash equivalents 4,736 (477)
Cash and cash equivalents at beginning of period 4,985 6,759
Cash and cash equivalents at end of period $ 9,721 $ 6,282
[1] Amounts derived from the audited financial statements for the year ended December 31, 2019.